IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v12y2021i1d10.1038_s41467-021-24334-y.html
   My bibliography  Save this article

Identification of 22 susceptibility loci associated with testicular germ cell tumors

Author

Listed:
  • John Pluta

    (University of Pennsylvania)

  • Louise C. Pyle

    (Children’s Hospital of Philadelphia)

  • Kevin T. Nead

    (University of Pennsylvania)

  • Rona Wilf

    (University of Pennsylvania)

  • Mingyao Li

    (University of Pennsylvania)

  • Nandita Mitra

    (University of Pennsylvania)

  • Benita Weathers

    (University of Pennsylvania)

  • Kurt D’Andrea

    (University of Pennsylvania)

  • Kristian Almstrup

    (Rigshospitalet)

  • Lynn Anson-Cartwright

    (University of Toronto and The Princess Margaret Cancer Centre)

  • Javier Benitez

    (Spanish National Cancer Centre (CNIO))

  • Christopher D. Brown

    (University of Pennsylvania)

  • Stephen Chanock

    (National Cancer Institute)

  • Chu Chen

    (University of Washington)

  • Victoria K. Cortessis

    (Keck School of Medicine at the University of Southern California)

  • Alberto Ferlin

    (University of Brescia)

  • Carlo Foresta

    (University of Padova)

  • Marija Gamulin

    (University Hospital Centre Zagreb, University of Zagreb School of Medicine)

  • Jourik A. Gietema

    (University Medical Center Groningen, University of Groningen)

  • Chiara Grasso

    (University of Turin and CPO-Piemonte)

  • Mark H. Greene

    (National Cancer Institute)

  • Tom Grotmol

    (Cancer Registry of Norway)

  • Robert J. Hamilton

    (University of Toronto and The Princess Margaret Cancer Centre)

  • Trine B. Haugen

    (Faculty of Health Sciences, OsloMet—Oslo Metropolitan University)

  • Russ Hauser

    (Harvard T.H. Chan School of Public Health)

  • Michelle A. T. Hildebrandt

    (University of Texas MD Anderson Cancer Center)

  • Matthew E. Johnson

    (Children’s Hospital of Philadelphia
    Children’s Hospital of Philadelphia)

  • Robert Karlsson

    (Karolinska Institutet)

  • Lambertus A. Kiemeney

    (Radboud University Medical Center)

  • Davor Lessel

    (University Medical Center Hamburg-Eppendorf)

  • Ragnhild A. Lothe

    (Oslo University Hospital-Radiumhospitalet
    University of Oslo)

  • Jennifer T. Loud

    (National Cancer Institute)

  • Chey Loveday

    (The Institute of Cancer Research)

  • Paloma Martin-Gimeno

    (Spanish National Cancer Centre (CNIO))

  • Coby Meijer

    (University Medical Center Groningen, University of Groningen)

  • Jérémie Nsengimana

    (Newcastle University)

  • David I. Quinn

    (Division of Oncology, Keck School of Medicine at the University of Southern California)

  • Thorunn Rafnar

    (deCODE Genetics/Amgen)

  • Shweta Ramdas

    (University of Pennsylvania)

  • Lorenzo Richiardi

    (University of Turin and CPO-Piemonte)

  • Rolf I. Skotheim

    (Oslo University Hospital-Radiumhospitalet
    University of Oslo)

  • Kari Stefansson

    (deCODE Genetics/Amgen)

  • Clare Turnbull

    (University of Oslo
    Queen Mary University)

  • David J. Vaughn

    (University of Pennsylvania
    University of Pennsylvania)

  • Fredrik Wiklund

    (Karolinska Institutet)

  • Xifeng Wu

    (Zhejiang University)

  • Daphne Yang

    (University of Pennsylvania)

  • Tongzhang Zheng

    (Brown University)

  • Andrew D. Wells

    (Children’s Hospital of Philadelphia
    University of Pennsylvania)

  • Struan F. A. Grant

    (Children’s Hospital of Philadelphia
    University of Pennsylvania
    Children’s Hospital of Philadelphia)

  • Ewa Rajpert-De Meyts

    (Rigshospitalet)

  • Stephen M. Schwartz

    (University of Washington)

  • D. Timothy Bishop

    (University of Leeds)

  • Katherine A. McGlynn

    (National Cancer Institute)

  • Peter A. Kanetsky

    (H. Lee Moffitt Cancer Center and Research Institute)

  • Katherine L. Nathanson

    (University of Pennsylvania
    University of Pennsylvania)

Abstract

Testicular germ cell tumors (TGCT) are the most common tumor in young white men and have a high heritability. In this study, the international Testicular Cancer Consortium assemble 10,156 and 179,683 men with and without TGCT, respectively, for a genome-wide association study. This meta-analysis identifies 22 TGCT susceptibility loci, bringing the total to 78, which account for 44% of disease heritability. Men with a polygenic risk score (PRS) in the 95th percentile have a 6.8-fold increased risk of TGCT compared to men with median scores. Among men with independent TGCT risk factors such as cryptorchidism, the PRS may guide screening decisions with the goal of reducing treatment-related complications causing long-term morbidity in survivors. These findings emphasize the interconnected nature of two known pathways that promote TGCT susceptibility: male germ cell development within its somatic niche and regulation of chromosomal division and structure, and implicate an additional biological pathway, mRNA translation.

Suggested Citation

  • John Pluta & Louise C. Pyle & Kevin T. Nead & Rona Wilf & Mingyao Li & Nandita Mitra & Benita Weathers & Kurt D’Andrea & Kristian Almstrup & Lynn Anson-Cartwright & Javier Benitez & Christopher D. Bro, 2021. "Identification of 22 susceptibility loci associated with testicular germ cell tumors," Nature Communications, Nature, vol. 12(1), pages 1-13, December.
    • Handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-24334-y
    DOI: 10.1038/s41467-021-24334-y
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-021-24334-y
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-021-24334-y?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Kyuto Sonehara & Yui Kimura & Yoshiko Nakano & Tatsuya Ozawa & Meiko Takahashi & Ken Suzuki & Takashi Fujii & Yuko Matsushita & Arata Tomiyama & Toshihiro Kishikawa & Kenichi Yamamoto & Tatsuhiko Nait, 2022. "A common deletion at BAK1 reduces enhancer activity and confers risk of intracranial germ cell tumors," Nature Communications, Nature, vol. 13(1), pages 1-9, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-24334-y. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.